---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-087217"
form_type: "8-K/A"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:44:00.551258+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vyome corrected pro forma statements show combined net loss $522k, revenue $249k for H1 2025

## Summary
- Corrected pro forma for H1 2025: combined net loss $522k, revenue $249k, EPS $(0.07).
- Vyome shareholders to own 92.4% of combined company on fully-diluted basis post-merger.
- Asset sale to Biorad for $1.6M in cash; concurrent financing totals $7.3M, including $660k bridge notes.
- Pro forma weighted-average shares of 7,191,409; combined total assets $6.95M, equity $4.79M.
- Merger closed August 14, 2025; filing corrects previously erroneous pro forma calculations.

## SEC filing metadata
- accession: 0001213900-25-087217
- form_type: 8-K/A
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000121390025087217/0001213900-25-087217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000121390025087217/ea0257032-8ka1_vyome.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-087217
- JSON: https://secwatch.observer/filing/0001213900-25-087217.json
- Plain text: https://secwatch.observer/filing/0001213900-25-087217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.